Status | Study |
Active, not recruiting |
Study Name: Safety Study of TPI-287 to Treat CBS and PSP Condition: Primary Four Repeat Tauopathies (4RT) Corticobasal Syndrome (CB Date: 2014-05-06 Interventions: Drug: TPI 287 2 mg/m2 2 mg/m2 |
Recruiting |
Study Name: Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography. Condition: Essential Tremor Multiple System Atrophy Date: 2014-05-02 |
Recruiting |
Study Name: Genetic Characterization of Movement Disorders and Dementias Condition: Ataxia Dystonia Parkinson's Disease Date: 2013-12-12 |
Active, not recruiting |
Study Name: 4 Repeat Tauopathy Neuroimaging Initiative Condition: Progressive Supranuclear Palsy Corticobasal Degeneration Date: 2013-01-18 Interventions: Other: Observational Study |
Completed |
Study Name: Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration Condition: Progressive Supranuclear Palsy Corticobasal Degeneration Date: 2010-07-28 |
Active, not recruiting |
Study Name: Davunetide (AL-108) in Predicted Tauopathies - Pilot Study Condition: Predicted Tauopathies, Including Progressive Supranuclear Palsy Date: 2010-01-21 Interventions: Drug: davunetide (AL-108, NAP) |
Completed |
Study Name: A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration Condition: Progressive Supranuclear Palsy Corticobasal Degeneration Date: 2008-06-20 Interventions: Drug: Lithium All participants will receive lithium. The dosage will be titrated over a 5-week period an |
Completed |
Study Name: Electrical Polarization of the Brain in Corticobasal Syndrome Condition: Corticobasal Syndrome Date: 2006-01-07 Interventions: Device: Phoresor II |